Bashir Al Hussein Al Awamlh, Christopher J D Wallis, David F Penson, Li-Ching Huang, Zhiguo Zhao, Ralph Conwill, Ruchika Talwar, Alicia K Morgans, Michael Goodman, Ann S Hamilton, Xiao-Cheng Wu, Lisa E Paddock, Antoinette Stroup, Brock B O'Neil, Tatsuki Koyama, Karen E Hoffman, Daniel A Barocas
IMPORTANCE: Adverse outcomes associated with treatments for localized prostate cancer remain unclear. OBJECTIVE: To compare rates of adverse functional outcomes between specific treatments for localized prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: An observational cohort study using data from 5 US Surveillance, Epidemiology, and End Results Program registries. Participants were treated for localized prostate cancer between 2011 and 2012...
January 23, 2024: JAMA